UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats Journal article
Li, Qiao Ping, Dou, Yao Xing, Huang, Zi Wei, Chen, Han Bin, Li, Yu Cui, Chen, Jian Nan, Liu, Yu Hong, Huang, Xiao Qi, Zeng, Hui Fang, Yang, Xiao Bo, Su, Zi Ren, Xie, Jian Hui. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats[J]. Phytomedicine, 2021, 85, 153550.
Authors:  Li, Qiao Ping;  Dou, Yao Xing;  Huang, Zi Wei;  Chen, Han Bin;  Li, Yu Cui; et al.
Favorite | TC[WOS]:34 TC[Scopus]:36  IF:6.7/6.2 | Submit date:2021/12/07
Ampk Signaling Pathway  Berberine  Insulin Signaling Pathway  Non-alcoholic Fatty Liver Disease  Obesity  Oxyberberine  
PH-Responsive de-PEGylated nanoparticles based on triphenylphosphine-quercetin self-assemblies for mitochondria-targeted cancer therapy Journal article
Lei Xing, Jin-Yuan Lyu, Yue Yang, Peng-Fei Cui, Liu-Qing Gu, Jian-Bin Qiao, Yu-Jing He, Tian-Qi Zhang, Minjie Sun, Jin-Jian Lu, Xiaojun Xu, Yu Liu, Hu-Lin Jiang. PH-Responsive de-PEGylated nanoparticles based on triphenylphosphine-quercetin self-assemblies for mitochondria-targeted cancer therapy[J]. Chemical Communications, 2017, 53(62), 8790-8793.
Authors:  Lei Xing;  Jin-Yuan Lyu;  Yue Yang;  Peng-Fei Cui;  Liu-Qing Gu; et al.
Favorite | TC[WOS]:40 TC[Scopus]:45 | Submit date:2018/12/28